Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Phase I, Single-Center, Evaluation of the Safety and Tolerability of Nitric Oxide Impregnated Urinary Catheters in Patients Undergoing Radical Prostatectomy

NCT02277171 is registered in ClinicalTrials.gov with Enox Israel Ltd as lead sponsor.

NCT NCT02277171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02277171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Phase I, Single-Center, Evaluation of the Safety and Tolerability of Nitric Oxide Impregnated Urinary Catheters in Patients Undergoing Radical Prostatectomy
Lead sponsor
Enox Israel Ltd
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2014
Completion date
September 30, 2015
Enrollment
15 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bacteriuria, urinary tract infection